New hope to keep cancer treatment on track
NCT ID NCT07162519
Summary
This study is testing if a drug called romiplostim N01 can help breast cancer patients recover their platelet counts after chemotherapy. Low platelets (thrombocytopenia) are a common side effect that can delay cancer treatment. The study will see if weekly injections of the drug can boost platelet counts quickly, allowing patients to resume their anti-cancer therapy on schedule.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for BREAST CANCER are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Conditions
Explore the condition pages connected to this study.